跳至主要内容
临床试验/NCT00415272
NCT00415272终止不适用

Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease

University of California, San Francisco2 个研究点 分布在 1 个国家开始时间: 2006年12月22日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
试验地点
2

研究概览

简要总结

Our study aims to investigate the benefits of an outpatient pulmonary rehabilitation program in a population of subjects with fibrotic interstitial lung disease. Our hypothesis is that pulmonary rehabilitation will lead to improvements in quality of life, breathlessness, exercise capacity and pulmonary function in this patient population.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Restriction on pulmonary function testing (TLC <80%, FEV1/FVC ratio > predicted or DLCO < 80%)
  • Evidence of fibrosis on high resolution computed tomography of the chest.
  • Fibrosis on surgical lung biopsy if performed
  • Referral for pulmonary rehabilitation

排除标准

  • Participation in pulmonary rehabilitation in the past 24 months
  • Inability to complete 6 minute walk test or study questionnaires
  • Limitations other than dyspnea (e.g. arthritis) that affect ability to participate in pulmonary rehabilitation
  • Baseline 6 minute walk distance > 400 meters
  • Planned change in medication treatment for lung disease during the course of pulmonary rehabilitation
  • Ejection fraction known to be < 25%
  • Contraindications to pulmonary rehabilitation (clinically unstable, uncontrolled arrhythmia or hypertension, symptomatic or uncontrolled hypotension with systolic blood pressure of < 95, active angina, unexplained syncope or worsening dizziness, limiting orthopedic or neurological disorders, psychiatric impairment that inhibits cooperation in the program)
  • FEV1/FVC < 65%
  • Unable to provide informed consent

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Pulmonary Rehabilitation in Patients With Fibrotic... | 临床试验